Web Search: Goods Information jobs Download
关于我们

MnO2

 

 

MATERIAL SAFETY DATA SHEET

 

MANGANESE OXIDE, MnO2

 

--------------------------------------------------------------------------------------------------------------------------------------------

 

GENERAL

 

--------------------------------------------------------------------------------------------------------------------------------------------

COMPANY'S NAME: Huizhou TianYi Rare Material Co.,Ltd

 

COMPANY'S TEL #:    0086-752-2021182

 

COMPANY'S Address:   12K of Shiji, Shijixingtian Bldg, YanDa Road, Huizhou China      

 

DATE MSDS PREPARED: 03/05/06

 

DATE MSDS REVISED:          02/12/13

--------------------------------------------------------------------------------------------------------------------------------------------

 

1. PRODUCT IDENTIFICATION

 

--------------------------------------------------------------------------------------------------------------------------------------------

 

 

 

PRODUCT NAME:      MANGANESE OXIDE

 

 

CHEMICAL NATURE: METAL OXIDE

 

 

FORMULA:   MnO, MnO2

 

 

CAS #:   1344-43-0, 1313-13-9

 

 

MOLECULAR WEIGHT:     70.937

 

 

 

-------------------------------------------------------------------------------------------------------------------------------------------

 

2. PHYSICAL AND CHEMICAL CHARACTERISTICS

 

--------------------------------------------------------------------------------------------------------------------------------------------

 

BOILING POINT  N/A

 

MELTING POINT:       535C

 

 

 

SPECIFIC GRAVITY (H2O=1): NOT DETERMINED

 

 

 

DENSITY @ 200C:     5.026 g/cm3, 5.43-5.46 g/cm3

 

VAPOR PRESSURE:   N/A

 

EVAPORATION RATE N/A

 

% VOLATILES:    N/A

 

 

 

SOLUBILITY IN H2O: INSOLUBLE

 

 

 

APPEARANCE AND ODOR:     BLACK, GREEN, POWDER, GRANULES, SPUTTERING

 

 

 

TARGET, ODORLESS

 

 

 

-------------------------------------------------------------------------------------------------------------------------------------------

 

3. HAZARD IDENTIFICATION

 

--------------------------------------------------------------------------------------------------------------------------------------------

 

 

 

HAZARDOUS COMPONENTS %   

MAGNESIUM OXIDE: 100%

HAZARDOUS DESCRIPTION: 

OSHA/PEL    1 mg/m3

ACGIH/TLV   NO DATA

SEC.302 (EHS):   NO

SEC.313:      NO

SEC.304 RQ:       NO

HMIS RATINGS (Scale 0-4):    

MnO:  HEALTH: 1

FLAMMABILITY:  0

REACTIVITY:       0

MnO2:  HEALTH:      2

FLAMMABILITY:  0

REACTIVITY:       1

 

 

--------------------------------------------------------------------------------------------------------------------------------------------

 

4. FIRE FIGHTING MEASURES

 

--------------------------------------------------------------------------------------------------------------------------------------------

 

FLASH POINT:     N/A

 

METHOD USED: NON-COMBUSTIBLE

 

 

 

 

AUTOIGNITION TEMPERATURE:   N/A

FLAMMABLE LIMITS:             

UPPER: N/A

LOWER:       N/A

EXTINGUISHING MEDIA:  USE SUITABLE EXTINGUISHING MEDIA FOR   

SPECIAL FIRE FIGHTING SURROUNDING MATERIALS AND TYPE OF FIRE.  

             

PROCEDURES:   FIREFIGHTERS MUST WEAR FULL FACE, SELF-CONTAINED    

             

       BREATHING APPARATUS WITH FULL PROTECTIVE      

       CLOTHING TO PREVENT CONTACT WITH SKIN AND EYES.

       FUMES FROM FIRE ARE HAZARDOUS. ISOLATE RUNOFF  

UNUSUAL FIRE AND  TO PREVENT ENVIRONMENTAL POLLUTION. 

             

EXPLOSION HAZARDS:    WHEN HEATED TO DECOMPOSITION THIS MATERIAL MAY

       EMIT TOXIC FUMES.

 

 

 

--------------------------------------------------------------------------------------------------------------------------------------------

 

5. HEALTH HAZARD INFORMATION

 

--------------------------------------------------------------------------------------------------------------------------------------------

 

EFFECTS OF EXPOSURE:            

ACUTE EFFECTS:           

INHALATION:      IRRITANT    

SKIN:     IRRITANT    

EYE:      IRRITATING EFFECT

CHRONIC EFFECTS: CHRONIC EXPOSURE TO MANGANESE MAY CAUSE    

       IMAPIRMENT TO THE CENTRAL NERVOUS SYSTEM.   

       SYMPTOMS INCLUDE SLUGGISHNESS, SLEEPINESS, 

       MUSCLE WEAKNESS, LOSS OF FACIAL MUSCLE CONTROL,     

       EDEMA, EMOTIONAL DISTURBANCES, SPASTIC GAIT AND 

       FALLING. CHRONIC MANGANESE POISONING MAY     

       DEVELOP AFTER AS LITTLE AS THREE MONTHS OF HEAVY     

       EXPOSURE BUT USUALLY CASES DEVELOP AFTER ONE TO    

       THREE YEARS OF EXPOSURE.    

TARGET ORGANS:    MAY AFFECT THE CENTRAL NERVOUS SYSTEM, KIDNEYS,      

MEDICAL CONDITIONS    RESPIRATORY SYSTEM AND LIVER.  

             

POSSIBLY AGGRAVATED       

BY EXPOSURE:   IT HAS BEEN RECORDED THAT WHEN EXPOSED TO   

       MANGANESE DUST AND FUMES, THERE IS A HIGHER 

       INCIDENCE OF UPPER RESPIRATORY INFECTION AND      

       PNEUMONIA COMPARED TO THE GENERAL POPULATION.

 

 

 

--------------------------------------------------------------------------------------------------------------------------------------------

 

6. STABILITY

 

--------------------------------------------------------------------------------------------------------------------------------------------

 

STABILITY:   STABLE UNDER NORMAL TEMPERATURE AND PRESSURE.      

CONDITION TO AVOID:    NONE   

INCOMPATIBILITY           

(MATERIAL TO AVOID):    EASILY OXIDIZABLE MATERIALS AND REDUCING  

HAZARDOUS      AGENTS      

             

DECOMPOSITION PRODUCTS:     MANGANESE OXIDE FUME   

HAZARDOUS            

POLYMERIZATION:    NONE.  

 

 

 

--------------------------------------------------------------------------------------------------------------------------------------------

 

7. EMERGENCY AND FIRST AID PROCEDURES:

 

--------------------------------------------------------------------------------------------------------------------------------------------

 

 

 

INHALATION:      REMOVE VICTIM TO FRESH AIR; KEEP WARM AND QUIET;

 

 

 

GIVE OXYGEN IF BREATHING IS DIFFICULT AND SEEK

 

 

 

MEDICAL ATTENTION IMMEDIATELY.

 

 

 

INGESTION: GIVE 1-2 GLASSES OF MILK OR WATER AND INDUCE

 

 

 

VOMITING; IF GASTROINTESTINAL SYMPTOMS DEVELOP,

 

SEEK MEDICAL ATTENTION. NEVER INDUCE VOMITING

 

 

 

 

OR GIVE ANYTHING BY MOUTH TO AN UNCONSCIOUS

 

PERSON.

 

 

 

SKIN:     REMOVE CONTAMINATED CLOTHING; BRUSH MATERIAL

 

 

 

OFF SKIN; WASH AFFECTED AREA WITH MILD SOAP AND

 

 

 

WATER; IF REDNESS, ITCHING OR BURNING DEVELOPS,

 

 

 

SEEK MEDICAL ATTENTION.

 

EYE:      FLUSH EYES WITH LUKEWARM WATER, LIFTING UPPER

 

 

 

AND LOWER EYELIDS, FOR AT LEAST 15 MINUTES. SEEK

 

MEDICAL ATTENTION

 

--------------------------------------------------------------------------------------------------------------------

 

8. HANDLING AND STORAGE

 

--------------------------------------------------------------------------------------------------------------------------------------------

 

 

 

HANDLING:  WEAR APPROPRIATE RESPIRATORY AND PROTECTIVE

 

 

 

EQUIPMENT SPECIFIED IN SECTION VIII-CONTROL

 

 

 

MEASURES. ISOLATE SPILL AREA AND PROVIDE

 

 

 

VENTILATION. SWEEP OR VACUUM UP SPILL USING A HIGH

 

 

 

EFFICIENCY PARTICULATE ABSOLUTE (HEPA) AIR FILTER

 

 

 

AND PLACE IN A CLOSED CONTAINER FOR PROPER

 

 

 

DISPOSAL. TAKE CARE NOT TO RAISE DUST.

 

 

 

STORAGE:   STORE IN WELL VENTILATED COOL, DRY PLACE IN

 

 

 

TIGHTLY CLOSED CONTAINER. STORE AWAY FROM

 

 

 

OXIDISERS

 

--------------------------------------------------------------------------------------------------------------------------------------------

 

9. SPILL OR LEAK PROCEDURES

 

--------------------------------------------------------------------------------------------------------------------------------------------

 

STEPS TO BE TAKEN IN

 

CASE MATERIAL IS

 

 

 

RELEASED OR SPILLED: VACUUM OR SWEEP UP MATERIAL AND PLACE INTO A

 

 

 

SUITABLE DISPOSAL CONTAINER. CLEAN UP SPILLS

 

 

 

QUICKLY. AVOID TO CREAT DUSTING.WELL

 

VENTILATION.

 

 

 

RESPIRATORY PROTECTION:       AVOID INHALATION.

 

 

 

VENTILATION:    USE WITH ADEQUATE VENTILATION.

 

 

 

PROTECTIVE GLOVES:    RECOMMENED

 

 

 

EYE PROTECTION:   AVOID EYE CONTACT.

 

 

 

WASTE DISPOSAL METHOD:  DISPOSE OF IN ACCORDANCE WITH LOCAL, STATE AND

 

FEDERAL REGULATIONS

 

--------------------------------------------------------------------------------------------------------------------------------------------

 

10. TOXICITY DATA

 

--------------------------------------------------------------------------------------------------------------------------------------------

 

 

 

ACUTE TOXICITY:     LD50 (ORAL) >3478 mg/kg

 

 

 

IRRITANT EFFECT ON SKIN AND EYE

 

 

 

NO SENSITIZING EFFECT KNOWN

 

 

 

SUB ACUTE TO CHRONIC TOXICITY  CHRONIC INHALATION OF MANGANESE COMPOUNDS' DUST

 

 

 

PARTICLES, APPROXIMATELY 3 UM IN SIZE, FOR A PERIOD

 

 

 

OF A FEW MONTHS MAY CAUSE PULMONARY

 

 

 

PNEUMONITIS. MANGANESE COMPOUNDS MAY ALSO

 

 

 

CAUSE MANGANISM, PSYCHIC AND NEUROLOGICAL

 

 

 

DISORDERS EFFECTING THE CENTRAL NERVOUS SYSTEM,

 

 

 

TO DEVELOP

 

 

 

CARCINOGENICITY:  NONE

 

 

 

--------------------------------------------------------------------------------------------------------------------------------------------

 

11. TRANSPORTATION DATA

 

--------------------------------------------------------------------------------------------------------------------------------------------

 

 

 

D.O.T. NOT REGULATED

 

 

 

UN NUMBER:      NONE

 

 

 

HAZARD CLASS: NONE

 

 

 

ADR//RID CLASS:       NONE

 

 

 

IMDG CLASS:      NONE

 

 

 

AIR TRAN. ICAO/IATA CLASS: NONE

 

 

 

MARITIME TRAN. IMDG CLASS:    NONE

 

--------------------------------------------------------------------------------------------------------------------------------------------

 

12. REGULATIONS

 

 

--------------------------------------------------------------------------------------------------------------------------------------------

 

 

 

HAZARD SYMBOLS:  Xn HARMFUL

 

 

 

RISH PHRASES:  20/21/22 HARMFUL BY INHALATION, IN CONTACT WITH

 

 

 

SKIN AND IF SWALLOWED

 

 

 

36/37/38 IRRITATING TO EYES, RESPIRATORYSYSTEM AND

 

 

 

SKIN

 

 

 

--------------------------------------------------------------------------------------------------------------------------------------------

 

13. OTHER INFORMATION

 

--------------------------------------------------------------------------------------------------------------------------------------------

 

THIS SAFETY DATA SHEET SHOULD BE USED IN CONJUNCTION WITH TECHNICAL SHEETS. IT DOES NOT REPLACE THEM. THE INFORMATION GIVEN IS BASED ON OUR KNOWLEDGE OF THIS PRODUCT, AT THE TIME OF PUBLICATION. IT IS GIVEN IN GOOD FAITH. THE ATTENTION OF THE USER IS DRAWN TO THE POSSIBLE RISKS INCURRED BY USING THE PRODUCT FOR ANY OTHER PURPOSE OTHER THAN THAT FOR WHICH IT WAS INTENDED. THIS DOES NOT IN ANY WAY EXCUSE THE USER FROM KNOWING AND APPLYING ALL THE REGULATIONS GOVERNING HIS ACTIVITY. IT IS THE SOLE RESPONSIBILITY OF THE USER TO TAKE ALL PRECAUTIONS REQUIRED IN HANDLING THE PRODUCT. THE AIM OF THE MANDATORY REGULATIONS MENTIONED IS TO HELP THE USER TO FULFILL HIS OBLIGATIONS REGARDING THE USE OF HAZARDOUS PRODUCTS.